Intermolecular Inc. (IMI) 1.81 $IMI
Intermolecular Announces First Quarter 2016 Financial Results
PR Newswire - Thu May 05, 3:25PM CDT
Intermolecular, Inc. (NASDAQ: IMI) today reported results for its first quarter of fiscal 2016 ended March 31, 2016.
IMI: 1.81 (-0.03)
ReRAM Technology Now Available Through Intermolecular's New "IMI Discoveries" Licensed Products Business
PR Newswire - Thu May 05, 8:20AM CDT
Intermolecular, Inc. (NASDAQ: IMI), the trusted partner for advanced materials innovation, today announced that its ReRAM technology is now available for licensing, marking the launch of the company's new IMI Discoveries licensed products business.
IMI: 1.81 (-0.03)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Intermolecular, Inc. - IMI
ACCESSWIRE - Wed Apr 20, 10:36AM CDT
NEW YORK, NY / ACCESSWIRE / April 20, 2016 / Levi & Korsinsky announces it has commenced an investigation of Intermolecular, Inc. (NASDAQGS: IMI) concerning possible breaches of fiduciary duty by its Board of Directors. To obtain additional information, GO TO: http://zlk.9nl.com/intermolecular-imi or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
IMI: 1.81 (-0.03)
Purcell Julie & Lefkowitz LLP Is Investigating Intermolecular, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
PR Newswire - Wed Apr 20, 8:41AM CDT
Shareholder rights law firm Purcell Julie & Lefkowitz LLP has commenced an investigation of Intermolecular, Inc. (NASDAQ: IMI) concerning possible breaches of fiduciary duty by its board of directors.
IMI: 1.81 (-0.03)
Intermolecular Files Fiscal Year 2015 Financial Statements
PR Newswire - Mon Mar 28, 3:45PM CDT
Intermolecular, Inc. (NASDAQ: IMI) today filed its annual report on Form 10-K for the full year ended December 31, 2015.
IMI: 1.81 (-0.03)
Can The Uptrend Continue for Intermolecular (IMI)?
Zacks Equity Research - Zacks Investment Research - Mon Mar 14, 8:45AM CDT
Investors certainly have to be happy with Intermolecular, Inc. (IMI) and its short term performance
IMI: 1.81 (-0.03)
Intermolecular reports 4Q loss
Automated Insights - Thu Feb 04, 5:13PM CST
SAN JOSE, Calif. (AP) _ Intermolecular Inc. (IMI) on Thursday reported a loss of $1.9 million in its fourth quarter.
IMI: 1.81 (-0.03)
Intermolecular Reports Fourth Quarter 2015 and Full Year 2015 Financial Results
PR Newswire - Thu Feb 04, 3:16PM CST
Intermolecular, Inc. (NASDAQ: IMI) today reported results for its fourth quarter and full year ended December 31, 2015.
IMI: 1.81 (-0.03)
Intermolecular to Report Fourth Quarter and Fiscal 2015 Financial Results on February 4, 2016
BusinessWire - Thu Jan 21, 3:15PM CST
Intermolecular, Inc. (NASDAQ: IMI) -- a leader in engineered materials solutions -- today announced it will release financial results for the fourth quarter and fiscal year ended December 31, 2015 after the U.S. financial markets close on Thursday, February 4, 2016. In conjunction with the release, Intermolecular will host a conference call and simultaneous audio-only webcast at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time with Bruce McWilliams, president and chief executive officer, and Rick Neely, senior vice president and chief financial officer, for Intermolecular.
IMI: 1.81 (-0.03)
Intermolecular (IMI) Jumps: Stock Adds 8% in Session
Zacks Equity Research - Zacks Investment Research - Wed Dec 30, 7:40AM CST
Intermolecular, Inc. (IMI) saw its shares rise almost 8% in the last trading session.
FN: 36.57 (-1.32), IMI: 1.81 (-0.03)
Intermolecular Announces New Developments in its Relationship With Micron
BusinessWire - Mon Nov 23, 4:33PM CST
Intermolecular, Inc. (NASDAQ:IMI) - a leader in engineered materials solutions - today announced that its Collaborative Development Program ("CDP"
agreement with Micron Technology, Inc. ("Micron" will conclude on April 1, 2016. "Micron is a valued customer that Intermolecular hopes to serve well into the future, but the CDP model has proven too restrictive for both companies," stated Bruce McWilliams, President and CEO of Intermolecular. "Under the terms of the agreement, next April is the first opportunity for the companies to end the CDP, and last week we received Micron's notice of termination effective April 1, 2016. Until then, the companies will continue to work together under the terms of the CDP agreement, and we will seek to transition Micron's DRAM work to our new business model."
IMI: 1.81 (-0.03)
Intermolecular Announces Third Quarter 2015 Results
BusinessWire - Thu Nov 05, 3:15PM CST
Intermolecular, Inc. (NASDAQ:IMI) - a leader in engineered materials solutions - today announced results for its third quarter ended September 30, 2015
IMI: 1.81 (-0.03)
Intermolecular to Report Third Quarter 2015 Financial Results on November 5, 2015
BusinessWire - Thu Oct 15, 3:10PM CDT
Intermolecular, Inc. (NASDAQ:IMI) -- a leader in engineered materials solutions -- today announced it will release financial results for the fiscal third quarter ended September 30, 2015 after the U.S. financial markets close on Thursday, November 5, 2015. In conjunction with the release, Intermolecular will host a conference call and simultaneous audio-only webcast at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time with Bruce McWilliams, president and chief executive officer, and Rick Neely, senior vice president and chief financial officer, for Intermolecular.
IMI: 1.81 (-0.03)
Intermolecular (IMI) Catches Eye: Stock Moves 6.4% Higher
Zacks Equity Research - Zacks Investment Research - Fri Oct 09, 7:20AM CDT
Intermolecular, Inc. (IMI) was a big mover last session, as the company saw its shares rise more than 6% on the day.
NJ: 18.11 (-0.26), IMI: 1.81 (-0.03)
Intermolecular Announces Second Quarter 2015 Results
BusinessWire - Thu Aug 06, 3:18PM CDT
Intermolecular, Inc. (NASDAQ:IMI) - accelerating research and development (R&D) for advanced materials - today announced results for its second quarter ended June 30, 2015.
IMI: 1.81 (-0.03)
Intermolecular to Report Second Quarter 2015 Financial Results on August 6, 2015
BusinessWire - Thu Jul 16, 3:15PM CDT
Intermolecular, Inc. (NASDAQ:IMI)--accelerating research and development for semiconductor and clean energy industries--today announced it will release financial results for the fiscal second quarter ended June 30, 2015 after the U.S. financial markets close on Thursday, August 6, 2015. In conjunction with the release, Intermolecular will host a conference call and simultaneous audio-only webcast at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time with Bruce McWilliams, president and chief executive officer, and Rick Neely, senior vice president and chief financial officer, for Intermolecular.
IMI: 1.81 (-0.03)
Intermolecular Announces First Quarter 2016 Financial Results
PR Newswire - Thu May 05, 3:25PM CDT
Intermolecular, Inc. (NASDAQ: IMI) today reported results for its first quarter of fiscal 2016 ended March 31, 2016.
IMI: 1.81 (-0.03)
ReRAM Technology Now Available Through Intermolecular's New "IMI Discoveries" Licensed Products Business
PR Newswire - Thu May 05, 8:20AM CDT
Intermolecular, Inc. (NASDAQ: IMI), the trusted partner for advanced materials innovation, today announced that its ReRAM technology is now available for licensing, marking the launch of the company's new IMI Discoveries licensed products business.
IMI: 1.81 (-0.03)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Intermolecular, Inc. - IMI
ACCESSWIRE - Wed Apr 20, 10:36AM CDT
NEW YORK, NY / ACCESSWIRE / April 20, 2016 / Levi & Korsinsky announces it has commenced an investigation of Intermolecular, Inc. (NASDAQGS: IMI) concerning possible breaches of fiduciary duty by its Board of Directors. To obtain additional information, GO TO: http://zlk.9nl.com/intermolecular-imi or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
IMI: 1.81 (-0.03)
Purcell Julie & Lefkowitz LLP Is Investigating Intermolecular, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
PR Newswire - Wed Apr 20, 8:41AM CDT
Shareholder rights law firm Purcell Julie & Lefkowitz LLP has commenced an investigation of Intermolecular, Inc. (NASDAQ: IMI) concerning possible breaches of fiduciary duty by its board of directors.
IMI: 1.81 (-0.03)
Intermolecular Files Fiscal Year 2015 Financial Statements
PR Newswire - Mon Mar 28, 3:45PM CDT
Intermolecular, Inc. (NASDAQ: IMI) today filed its annual report on Form 10-K for the full year ended December 31, 2015.
IMI: 1.81 (-0.03)
Can The Uptrend Continue for Intermolecular (IMI)?
Zacks Equity Research - Zacks Investment Research - Mon Mar 14, 8:45AM CDT
Investors certainly have to be happy with Intermolecular, Inc. (IMI) and its short term performance
IMI: 1.81 (-0.03)
Intermolecular reports 4Q loss
Automated Insights - Thu Feb 04, 5:13PM CST
SAN JOSE, Calif. (AP) _ Intermolecular Inc. (IMI) on Thursday reported a loss of $1.9 million in its fourth quarter.
IMI: 1.81 (-0.03)
Intermolecular Reports Fourth Quarter 2015 and Full Year 2015 Financial Results
PR Newswire - Thu Feb 04, 3:16PM CST
Intermolecular, Inc. (NASDAQ: IMI) today reported results for its fourth quarter and full year ended December 31, 2015.
IMI: 1.81 (-0.03)
Intermolecular to Report Fourth Quarter and Fiscal 2015 Financial Results on February 4, 2016
BusinessWire - Thu Jan 21, 3:15PM CST
Intermolecular, Inc. (NASDAQ: IMI) -- a leader in engineered materials solutions -- today announced it will release financial results for the fourth quarter and fiscal year ended December 31, 2015 after the U.S. financial markets close on Thursday, February 4, 2016. In conjunction with the release, Intermolecular will host a conference call and simultaneous audio-only webcast at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time with Bruce McWilliams, president and chief executive officer, and Rick Neely, senior vice president and chief financial officer, for Intermolecular.
IMI: 1.81 (-0.03)
Intermolecular (IMI) Jumps: Stock Adds 8% in Session
Zacks Equity Research - Zacks Investment Research - Wed Dec 30, 7:40AM CST
Intermolecular, Inc. (IMI) saw its shares rise almost 8% in the last trading session.
FN: 36.57 (-1.32), IMI: 1.81 (-0.03)
Intermolecular Announces New Developments in its Relationship With Micron
BusinessWire - Mon Nov 23, 4:33PM CST
Intermolecular, Inc. (NASDAQ:IMI) - a leader in engineered materials solutions - today announced that its Collaborative Development Program ("CDP"
agreement with Micron Technology, Inc. ("Micron" will conclude on April 1, 2016. "Micron is a valued customer that Intermolecular hopes to serve well into the future, but the CDP model has proven too restrictive for both companies," stated Bruce McWilliams, President and CEO of Intermolecular. "Under the terms of the agreement, next April is the first opportunity for the companies to end the CDP, and last week we received Micron's notice of termination effective April 1, 2016. Until then, the companies will continue to work together under the terms of the CDP agreement, and we will seek to transition Micron's DRAM work to our new business model." IMI: 1.81 (-0.03)
Intermolecular Announces Third Quarter 2015 Results
BusinessWire - Thu Nov 05, 3:15PM CST
Intermolecular, Inc. (NASDAQ:IMI) - a leader in engineered materials solutions - today announced results for its third quarter ended September 30, 2015
IMI: 1.81 (-0.03)
Intermolecular to Report Third Quarter 2015 Financial Results on November 5, 2015
BusinessWire - Thu Oct 15, 3:10PM CDT
Intermolecular, Inc. (NASDAQ:IMI) -- a leader in engineered materials solutions -- today announced it will release financial results for the fiscal third quarter ended September 30, 2015 after the U.S. financial markets close on Thursday, November 5, 2015. In conjunction with the release, Intermolecular will host a conference call and simultaneous audio-only webcast at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time with Bruce McWilliams, president and chief executive officer, and Rick Neely, senior vice president and chief financial officer, for Intermolecular.
IMI: 1.81 (-0.03)
Intermolecular (IMI) Catches Eye: Stock Moves 6.4% Higher
Zacks Equity Research - Zacks Investment Research - Fri Oct 09, 7:20AM CDT
Intermolecular, Inc. (IMI) was a big mover last session, as the company saw its shares rise more than 6% on the day.
NJ: 18.11 (-0.26), IMI: 1.81 (-0.03)
Intermolecular Announces Second Quarter 2015 Results
BusinessWire - Thu Aug 06, 3:18PM CDT
Intermolecular, Inc. (NASDAQ:IMI) - accelerating research and development (R&D) for advanced materials - today announced results for its second quarter ended June 30, 2015.
IMI: 1.81 (-0.03)
Intermolecular to Report Second Quarter 2015 Financial Results on August 6, 2015
BusinessWire - Thu Jul 16, 3:15PM CDT
Intermolecular, Inc. (NASDAQ:IMI)--accelerating research and development for semiconductor and clean energy industries--today announced it will release financial results for the fiscal second quarter ended June 30, 2015 after the U.S. financial markets close on Thursday, August 6, 2015. In conjunction with the release, Intermolecular will host a conference call and simultaneous audio-only webcast at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time with Bruce McWilliams, president and chief executive officer, and Rick Neely, senior vice president and chief financial officer, for Intermolecular.
IMI: 1.81 (-0.03)
